KAYE EDWARD M. MD 1522780 Data last updated 2024-05-15 07:34:05 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-18 | 2023-05-10 | 2023-05-10 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 5000.0 | 27.25 | 0.52 | 0.0 | Direct | Common Stock | CYTOKINETICS INC | code A | 18347.0 | 95.64 (CYTK) |
| 2023-07-05 | 2023-07-03 | 2023-07-03 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 374.0 | 2.0 | 0.04 | 33.36 | Direct | Common Stock | CYTOKINETICS INC | code A | 18721.0 | 95.64 (CYTK) |
| 2023-09-08 | 2023-03-27 | 2023-03-27 | 4 | Kaye Edward M. Md | CEO | acq | 20000.0 | 44.44 | 4.52 | 0.6 | Direct | Common Stock | STOKE THERAPEUTICS, INC. | code M | 45000.0 | 44.26 (STOK) |
| 2023-10-03 | 2023-10-02 | 2023-10-02 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 448.0 | 2.34 | 0.05 | 27.88 | Direct | Common Stock | CYTOKINETICS INC | code A | 19169.0 | 96.0 (CYTK) |
| 2024-01-03 | 2024-01-02 | 2024-01-02 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 148.0 | 0.77 | 0.02 | 84.12 | Direct | Common Stock | CYTOKINETICS INC | code A | 19317.0 | 98.05 (CYTK) |
| 2024-03-19 | 2024-03-15 | 2024-03-19 | 4 | Kaye Edward M. Md | CEO | dsp | 11150.0 | 13.85 | 2.5 | 6.1 | Direct | Common Stock | STOKE THERAPEUTICS, INC. | code S | 69350.0 | 44.65 (STOK) |
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Kaye Edward M. Md | CEO | acq | 35500.0 | 44.1 | 7.95 | 0.0 | Direct | Common Stock | STOKE THERAPEUTICS, INC. | code M | 80500.0 | 44.65 (STOK) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-18 | 2023-05-10 | 2023-05-10 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 10000.0 | 100.0 | 1.05 | 37.89 | Direct | Non Qualified Stock Option (Right To Buy) | CYTOKINETICS INC | code A | 10000.0 | 95.64 (CYTK) |
| 2023-09-08 | 2023-03-27 | 2023-03-27 | 4 | Kaye Edward M. Md | CEO | dsp | 20000.0 | 3.21 | 4.52 | 0.6 | Direct | Employee Stock Option (Right To Buy) | STOKE THERAPEUTICS, INC. | code M | 602801.0 | 44.26 (STOK) |
| 2023-06-20 | 2023-06-15 | 2023-06-15 | 4 | Kaye Edward M. Md | DIRECTOR | acq | 22000.0 | 100.0 | 3.11 | 12.48 | Direct | Stock Option (Right To Buy) | AVIDITY BIOSCIENCES, INC. | code A | 22000.0 | 70.82 (RNA) |
| 2023-12-05 | 2023-12-01 | 2023-12-01 | 4 | Kaye Edward M. Md | CEO | dsp | 200800.0 | 100.0 | 44.97 | 60.0 | Direct | Employee Stock Option (Right To Buy) | STOKE THERAPEUTICS, INC. | code D | 0.0 | 44.65 (STOK) |
| 2023-12-05 | 2023-12-01 | 2023-12-01 | 4 | Kaye Edward M. Md | CEO | acq | 25908.0 | 100.0 | 5.8 | 0.0 | Direct | Restricted Stock Unit (Rsu) | STOKE THERAPEUTICS, INC. | code A | 25908.0 | 44.65 (STOK) |
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Kaye Edward M. Md | CEO | dsp | 35500.0 | 25.0 | 7.95 | 0.0 | Direct | Restricted Stock Units | STOKE THERAPEUTICS, INC. | code M | 106500.0 | 44.65 (STOK) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)